Analyst Ratings For Boston Scientific (NYSE:BSX)
Today, Morgan Stanley raised its price target on Boston Scientific (NYSE:BSX) to $33.00 per share.
Some recent analyst ratings include
- 3/5/2018-Royal Bank of Canada Reiterated Rating of Top Pick.
- 2/23/2018-Piper Jaffray Companies initiated coverage with a Overweight rating.
- 2/2/2018-Jefferies Group Reiterated Rating of Hold .
- 1/17/2018-Canaccord Genuity Reiterated Rating of Buy.
- 1/16/2018-Needham & Company LLC Reiterated Rating of Buy.
- 1/10/2018-Barclays Reiterated Rating of Buy.
Recent Insider Trading Activity For Boston Scientific (NYSE:BSX)
Boston Scientific (NYSE:BSX) has insider ownership of 0.74% and institutional ownership of 91.04%.
- On 3/14/2018 Kevin J Ballinger, EVP, sold 42,803 with an average share price of $28.32 per share and the total transaction amounting to $1,212,180.96.
- On 3/5/2018 John Bradley Sorenson, SVP, sold 1,950 with an average share price of $27.43 per share and the total transaction amounting to $53,488.50.
- On 2/28/2018 David A Pierce, SVP, sold 4,508 with an average share price of $27.54 per share and the total transaction amounting to $124,150.32.
- On 2/21/2018 David A Pierce, SVP, sold 16,286 with an average share price of $27.00 per share and the total transaction amounting to $439,722.00.
- On 2/9/2018 Maulik Nanavaty, SVP, sold 15,568 with an average share price of $25.38 per share and the total transaction amounting to $395,115.84.
- On 2/7/2018 Joseph Michael Fitzgerald, EVP, sold 85,227 with an average share price of $26.48 per share and the total transaction amounting to $2,256,810.96.
- On 2/1/2018 David A Pierce, SVP, sold 5,152 with an average share price of $27.43 per share and the total transaction amounting to $141,319.36.
Recent Trading Activity for Boston Scientific (NYSE:BSX)
Shares of Boston Scientific closed the previous trading session at 27.65 down -0.28 1.00% with shares trading hands.